| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0087 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |